Citation only
via OpenAlex
Senolytics: Opening avenues in drug discovery to find novel therapeutics for Parkinson’s Disease
Violina Kakoty, Sarathlal Kalarikkal Chandran, Monica Gulati, Bey Hing Goh, Kamal Dua, Sachin Kumar Singh
Drug Discovery Today · 2023 · ▲ 7 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.drudis.2023.103582
- Canonical
- link ↗
- Fetched
- 2026-06-15 MST
Cite this
APA
Kakoty, V., Chandran, S.K., Gulati, M., Goh, B.H., Dua, K., & Singh, S.K. (2023). Senolytics: Opening avenues in drug discovery to find novel therapeutics for Parkinson’s Disease. <em>Drug Discovery Today</em>. https://doi.org/10.1016/j.drudis.2023.103582
Vancouver
Kakoty V, Chandran SK, Gulati M, Goh BH, Dua K, Singh SK. Senolytics: Opening avenues in drug discovery to find novel therapeutics for Parkinson’s Disease. Drug Discovery Today. 2023. doi:10.1016/j.drudis.2023.103582.
BibTeX
@article{violina2023Senoly,
title = {Senolytics: Opening avenues in drug discovery to find novel therapeutics for Parkinson’s Disease},
author = {Violina Kakoty and Sarathlal Kalarikkal Chandran and Monica Gulati and Bey Hing Goh and Kamal Dua and Sachin Kumar Singh},
journal = {Drug Discovery Today},
year = {2023},
doi = {10.1016/j.drudis.2023.103582},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Lancet 2021
Open access · OA
Parkinson's disease
The Lancet 2024
Preprint · CC-BY
The pathogenesis of Parkinson's disease
Journal of Allergy and Clinical Immunology 2020
Open access · OA
The microbiome and inflammatory bowel disease
Physiological Research 2013
Open access · CC-BY
Resveratrol and Related Compounds as Antioxidants With an Allosteric Mechanism of Action in Epigenetic Drug Targets
Ageing Research Reviews 2023
Preprint · OA
Role of diet and exercise in aging, Alzheimer’s disease, and other chronic diseases
The American Journal of Human Genetics 1998
Open access · OA